46 related articles for article (PubMed ID: 17334990)
1. Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results.
Meyer JL; Hanlon DW; Andersen BT; Rasmussen OF; Bisgaard K
Cancer; 2007 Apr; 111(2):83-92. PubMed ID: 17334990
[TBL] [Abstract][Full Text] [Related]
2. Validation of an on-chip p16
Hashimoto K; Kumagai T; Nomura K; Miyagawa Y; Tago S; Takasaki K; Takahashi Y; Nishida H; Ichinose T; Hirano M; Hiraike H; Wada-Hiraike O; Sasajima Y; Kim SH; Nagasaka K
Sci Rep; 2023 Oct; 13(1):17052. PubMed ID: 37816765
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Foxp3 participates in progression of cervical cancer.
Zeng C; Yao Y; Jie W; Zhang M; Hu X; Zhao Y; Wang S; Yin J; Song Y
Cancer Immunol Immunother; 2013 Mar; 62(3):481-7. PubMed ID: 22986453
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
[TBL] [Abstract][Full Text] [Related]
5. Elevated p16ink4a Expression in Human Labial Salivary Glands as a Potential Correlate of Cognitive Aging in Late Midlife.
Sørensen CE; Tritsaris K; Reibel J; Lauritzen M; Mortensen EL; Osler M; Pedersen AM
PLoS One; 2016; 11(3):e0152612. PubMed ID: 27029014
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A/p16 evaluation in cytology specimens.
Xing J; Griffith CC
Cancer Cytopathol; 2023 Nov; 131(11):672-676. PubMed ID: 37068112
[No Abstract] [Full Text] [Related]
7. To Evaluate the Role of p16
Verma L; Shamsunder S; Malik S; Arora R
J Cytol; 2020; 37(2):82-86. PubMed ID: 32606495
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
Hillemanns P; Friese K; Dannecker C; Klug S; Seifert U; Iftner T; Hädicke J; Löning T; Horn L; Schmidt D; Ikenberg H; Steiner M; Freitag U; Siebert U; Sroczynski G; Sauerbrei W; Beckmann MW; Gebhardt M; Friedrich M; Münstedt K; Schneider A; Kaufmann A; Petry KU; Schäfer APA; Pawlita M; Weis J; Mehnert A; Fehr M; Grimm C; Reich O; Arbyn M; Kleijnen J; Wesselmann S; Nothacker M; Follmann M; Langer T; Jentschke M
Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):160-176. PubMed ID: 30792546
[No Abstract] [Full Text] [Related]
9. Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care.
Peres AL; Paz E Silva KM; de Araújo RF; de Lima Filho JL; de Melo Júnior MR; Martins DB; de Pontes Filho NT
J Biomed Sci; 2016 May; 23(1):42. PubMed ID: 27175798
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care test for cervical cancer in LMICs.
Mohammed SI; Ren W; Flowers L; Rajwa B; Chibwesha CJ; Parham GP; Irudayaraj JM
Oncotarget; 2016 Apr; 7(14):18787-97. PubMed ID: 26934314
[TBL] [Abstract][Full Text] [Related]
11. Optimizing technology for cervical cancer screening in high-resource settings.
Richardson LA; Tota J; Franco EL
Expert Rev Obstet Gynecol; 2011 May; 6(3):343-353. PubMed ID: 26617667
[TBL] [Abstract][Full Text] [Related]
12. Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.
Zappacosta R; Colasante A; Viola P; D'Antuono T; Lattanzio G; Capanna S; Gatta DM; Rosini S
Biomed Res Int; 2013; 2013():453606. PubMed ID: 24369532
[TBL] [Abstract][Full Text] [Related]
13. [Immunocytochemistry of p16(INK4a) and Ki-67 as adjunctive method for routine gynecological cytology of mild and moderate dysplasia].
Ziemke P; Marquardt K
Pathologe; 2013 Jul; 34(4):323-8. PubMed ID: 22752390
[TBL] [Abstract][Full Text] [Related]
14. p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis.
Roelens J; Reuschenbach M; von Knebel Doeberitz M; Wentzensen N; Bergeron C; Arbyn M
Cancer Cytopathol; 2012 Oct; 120(5):294-307. PubMed ID: 22700382
[TBL] [Abstract][Full Text] [Related]
15. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs.
Brown CA; Bogers J; Sahebali S; Depuydt CE; De Prins F; Malinowski DP
J Oncol; 2012; 2012():289315. PubMed ID: 22481919
[TBL] [Abstract][Full Text] [Related]
16. Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.
Gertych A; Joseph AO; Walts AE; Bose S
Ann Biomed Eng; 2012 May; 40(5):1192-204. PubMed ID: 22215277
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of cervical dysplasia and carcinoma.
Hwang SJ; Shroyer KR
J Oncol; 2012; 2012():507286. PubMed ID: 22131995
[TBL] [Abstract][Full Text] [Related]
18. p16 immunocytochemistry on cell blocks as an adjunct to cervical cytology: Potential reflex testing on specially prepared cell blocks from residual liquid-based cytology specimens.
Shidham VB; Mehrotra R; Varsegi G; D'Amore KL; Hunt B; Narayan R
Cytojournal; 2011 Jan; 8():1. PubMed ID: 21369522
[TBL] [Abstract][Full Text] [Related]
19. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.
Andersson S; Sowjanya P; Wangsa D; Hjerpe A; Johansson B; Auer G; Gravitt PE; Larsson C; Wallin KL; Ried T; Heselmeyer-Haddad K
Am J Pathol; 2009 Nov; 175(5):1831-47. PubMed ID: 19880826
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
